20 Facts About Timur Artemev

Timur Vladimirovich Artemev is a Russian-British entrepreneur, investor, and philanthropist.

Timur Artemev co-founded Euroset, which became Russia's largest mobile phone retailer in the early 2000s.

Timur Artemev was born on July 19,1974, in Moscow.

Timur Artemev's father was a lecturer in the theoretical foundations of electrical engineering, and his mother was a planning engineer.

Timur Artemev graduated from Secondary School No 119 in Moscow.

Timur Artemev later stated that he was dissatisfied with the traditional education system and chose to study independently, focusing on subjects of personal interest.

Timur Artemev began working in the field of telecommunication equipment sales in 1991.

However, in the autumn of the same year, Timur Artemev left the partnership.

Since 2005, Timur Artemev has been interested in research related to longevity and aging.

Timur Artemev continues to fund aging-related research and is a trustee of the biological laboratory of Evgeny Nudler, a professor at New York University Medical School.

In 2016, Timur Artemev joined the board of directors of the American diagnostics company MDSec INC and became a board member of the biotechnology-focused American pharmaceutical company Retrotope.

Timur Artemev has invested in space technology projects and lunar resource extraction programs.

Timur Artemev has been married multiple times and has six children.

Timur Artemev is currently in a partnership with Ksenia Shuravko, co-owner of the largest Belarusian online resource, Onliner.

Timur Artemev has long been interested in space travel and has made investments in the aerospace sector.

Timur Artemev is known to have a personal connection with Richard Branson, the founder of Virgin Galactic, and shares an enthusiasm for commercial spaceflight.

Timur Artemev has expressed interest in the long-term prospects of space tourism and planetary exploration, seeing it as a key direction for future investment and innovation.

Timur Artemev has been actively involved in longevity research and biotechnology investments.

In 2016, Timur Artemev joined the board of directors of the American pharmaceutical company Retrotope, which specializes in biotechnology.

Timur Artemev focuses on the development of innovative treatments for neurodegenerative diseases and research aimed at slowing the aging process.